Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ODE Chief Foreman Departs Device Center; Maisel Will Fill In

This article was originally published in The Gray Sheet

Executive Summary

Christy Foreman is taking an associate director role in FDA’s Center for Tobacco Products, leaving a vacancy at the top of the Office of Device Evaluation. CDRH Chief Scientist William Maisel will fill in while the device center seeks a replacement.

You may also be interested in...



FDA Taps New Office of Device Evaluation Director From Industry

Device industry veteran John Sheets has been appointed as the new director of FDA's premarket review office for devices. It’s the second time this year that CDRH has tapped an industry executive to lead one of its offices.

'Acting' At CDRH: Two Top Device Offices Now Run By Interim Directors

An update on CDRH's management structure.

'Acting' At CDRH: Two Top Offices Are Now Run By Interim Directors

An update on CDRH's management structure.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT033247

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel